Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
261studies shown
Showing 73-84 of 261
Behavioral study icon
RecruitingNCT07033923

Neuro-computational Study of Thymic Fluctuations in Mood Disorders

This observational study is following people with Depression, bipolarity, or Recurrent Depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

Remote / online
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityBehavioralOver 18 Years
Countries
France
Sponsor
Centre Hospitalier St Anne
Condition
Depression, Bipolarity
Device study icon
Active Not RecruitingNCT06789822

Detection Algorithm for Recurrence or Relapse of Depression Thanks to a Smartwach

This study is looking at care and outcomes for people with depression, depression, depression, or depression Not Otherwise Specified. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
France
Sponsor
Dalia Care
Condition
Depression
Behavioral study icon
UnknownNCT05547035

Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders

This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In France
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
France
Sponsor
Digital For Mental Health
Condition
Depression
Drug study icon
CompletedNCT02417064

Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression

This study is completed in the United States, in France, in Canada, .... It is testing efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Behavioral study icon
CompletedNCT06661616

Cognitive Effects Associated With Hippocampal Neurogenesis Induced by ECT in the Treatment of Depression

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In France
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityOtherOver 18 Years
Countries
France
Sponsor
Centre Hospitalier St Anne
Condition
Depression, Bipolarity
Behavioral study icon
RecruitingNCT05632757

Anticipated Patient and Caregiver Burden

This summary needs review. Please check the official study record and contact the research team for details.

In France
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralOver 18 Years
Countries
France
Sponsor
Assistance Publique Hopitaux De Marseille
Condition
Depression
Behavioral study icon
RecruitingNCT05149742

Deafness and Cognition in Middle-aged Adults

This summary needs review. Please check the official study record and contact the research team for details.

In France
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 45 Years to 64 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
Depression
Drug study icon
CompletedEUCTR 2019-001989-15

Fremanezumab for Depression

This study is completed in France, in Germany, in Czechia, .... It is testing fremanezumab for Depression.

In France
Why is this study shown?

This study is directly about Depression.

DepressionOther
Countries
France, Germany, Czechia, ...
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.